QUANTUM GENOMICS

ALQGC
Real-time Euronext Paris - 09:06 2022-12-07 am EST
0.1445 EUR +0.35%

Turn to zoom
Prev.0.14400000
Open0.14550000
High0.14800000
Low0.14230000
Volume35 819
Latest news
10/28
10/28
10/28
10/28
Chart QUANTUM GENOMICS
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishBearishBearish
Resistance0,190,720,72
Spread/Res.-24%-80%-80%
Spread/Supp.2,0%2,0%275%
Support0,140,140,04
Financials
Sales 2022 6,54 M 6,88 M 6,88 M
Net income 2022 -6,29 M -6,62 M -6,62 M
Net cash 2022 12,7 M 13,4 M 13,4 M
P/E ratio 2022 -0,95x
Yield 2022 -
Capitalization 4,99 M 5,24 M 5,24 M
EV / Sales 2022 -1,18x
EV / Sales 2023 -0,25x
Nbr of Employees 8
Free-Float 90,8%
Company
Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure.

All sales are abroad.
Sector :
Other Biotechnology & Medical Research
Calendar :
2023-03-30 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 3
Last Close Price 0,14 €
Average target price 10,08 €
Spread / Average Target 6 897%